Aventyl and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Aventyl (nortriptyline hydrochloride), especially for people who are female, 60+ old, also take Celebrex, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Aventyl. It is created by eHealthMe based on reports of 462 people who have side effects when taking Aventyl from the FDA, and is updated regularly.

What is Aventyl?

Aventyl has active ingredients of nortriptyline hydrochloride. eHealthMe is studying from 515 Aventyl users. Check the latest studies of Aventyl.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,956 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 16, 2026

462 people reported to have side effects when taking Aventyl.
Among them, 12 people (2.6%) have Urinary tract infection.

Could Aventyl cause Urinary tract infection?

Among these 12 people:

What is the gender of people who have Urinary tract infection when taking Aventyl? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Urinary tract infection when taking Aventyl? *

What are other drugs people take besides Aventyl? *

What are other side effects people have besides Urinary tract infection? *

Peripheral Swelling: 6 people, 50.00%
Hypotension (abnormally low blood pressure): 6 people, 50.00%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 41.67%
Blood Potassium Decreased: 5 people, 41.67%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 41.67%
Weight Decreased: 5 people, 41.67%
Melanocytic Naevus (a type of lesion that contains nevus cells (a type of melanocyte)): 4 people, 33.33%
Abdominal Pain Lower: 4 people, 33.33%
Renal Disorder (kidney disease): 4 people, 33.33%
Pain: 4 people, 33.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 33.33%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 25.00%
Renal Cell Carcinoma (a kidney cancer): 2 people, 16.67%
Secondary Immunodeficiency (lack of immunity due to some disease): 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Neuropathy Peripheral (surface nerve damage): 1 person, 8.33%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 1 person, 8.33%
Gastric Ph Increased: 1 person, 8.33%
Cardiomyopathy (weakening of the heart muscle): 1 person, 8.33%
Breakthrough Pain: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aventyl and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aventyl:

Aventyl (515 reports)

Browse all side effects of Aventyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nortriptyline hydrochloride (the active ingredients of Aventyl) and Aventyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.